BFNH

BioForce Nanosciences Holdings, Inc.

6 transactions on file, per SEC Form 4 filings.

KAISER RICHARD KAISER

CEO & CFO · 2026-08-31

Award

$174K

KAISER RICHARD KAISER

CEO & CFO · 2026-08-20

J-Other

$25K

Ferguson Merle

director · 2026-04-22

Sold

$401K

Ferguson Merle

director · 2026-04-20

G-Gift

$144K

Ferguson Merle

director · 2026-04-20

G-Gift

$4K

KAISER RICHARD KAISER

CEO & CFO · 2026-04-20

G-Gift

$4K

Each row links to the underlying SEC filing. Sells are shown for transparency, not as a signal — see the insider trading article for why.

Is BFNH actually a buy?

Following an insider into a stock isn't a strategy on its own. Run your own margin-of-safety analysis, free.